ClearPoint Neuro, Inc. (CLPT)
After hours:
| Previous close | 5.50 |
| Open | 5.52 |
| Bid | 5.31 x 100 |
| Ask | 5.36 x 100 |
| Day's range | 5.27 - 5.52 |
| 52-week range | 4.05 - 10.80 |
| Volume | |
| Avg. volume | 151,891 |
| Market cap | 148.883M |
| Beta (5Y monthly) | 0.92 |
| PE ratio (TTM) | N/A |
| EPS (TTM) | -0.90 |
| Earnings date | 07 May 2024 |
| Forward dividend & yield | N/A (N/A) |
| Ex-dividend date | N/A |
| 1y target est | 10.00 |
GlobeNewswireClearPoint Neuro Announces Initiation of Limited Market Release for the SmartFrame OR™ Stereotactic System
More than Ten Operating Room Procedures Complete with Multiple Sites Reordering and Scheduling Cases SmartFrame OR logo SmartFrame OR SOLANA BEACH, Calif., April 24, 2024 (GLOBE NEWSWIRE) -- ClearPoint Neuro, Inc. (Nasdaq: CLPT) (the “Company”), a global device, cell, and gene therapy-enabling company offering precise navigation to the brain and spine, today announced it has initiated the Limited Market Release for its SmartFrame OR™ Stereotactic System. “Expanding ClearPoint’s portfolio beyond
GlobeNewswireClearPoint Neuro to Announce First Quarter 2024 Results May 7, 2024
SOLANA BEACH, Calif., April 23, 2024 (GLOBE NEWSWIRE) -- ClearPoint Neuro, Inc. (Nasdaq: CLPT) (the “Company”), a global device, cell, and gene therapy-enabling company offering precise navigation to the brain and spine, today announced that it will release financial results for its 2024 first quarter on Tuesday, May 7th, after the market close. Investors and analysts are invited to listen to the live broadcast review of the Company’s 2024 first quarter on Tuesday, May 7th, at 4:30 p.m. Eastern
Simply Wall St.Is There Now An Opportunity In ClearPoint Neuro, Inc. (NASDAQ:CLPT)?
ClearPoint Neuro, Inc. ( NASDAQ:CLPT ), might not be a large cap stock, but it saw significant share price movement...
